Yüklüyor......
Predicting Optimal Combination LT4 + LT3 Therapy for Hypothyroidism Based on Residual Thyroid Function
Objective: To gain insight into the mixed results of reported combination therapy studies conducted with levothyroxine (LT4) and liothyronine (LT3) between 1999 and 2016. Methods: We defined trial success as improved clinical outcome measures and/or patient preference for added LT3. We hypothesized...
Kaydedildi:
| Yayımlandı: | Front Endocrinol (Lausanne) |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6873785/ https://ncbi.nlm.nih.gov/pubmed/31803137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00746 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|